• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

AAV9.LAMP2B gene therapy shows clinical benefit in Danon disease

byNhat Hung (Benjamin) LamandKiera Liblik
August 29, 2026
in Cardiology, Chronic Disease
Reading Time: 3 mins read
Heart disease collage: a smiling older woman with short gray hair beside an engraved heart and a sprig of hawthorn
Share on FacebookShare on TwitterShare on LinkedIn

1. In seven patients with Danon disease, a single infusion of adeno-associated virus serotype 9 carrying transgene LAMP2B (AVV9.LAMP2B) therapy (RP-A501) resulted in cardiac expression of the lysosomal-associated membrane 2 (LAMP2) protein.

2. Clinical improvement was observed in six patients who had normal left ventricular ejection fraction (LVEF) at baseline.

Evidence Rating Level: 2 (Good)

Study Rundown: Danon disease is a rare X-linked disease characterized by mutations in the LAMP2 gene, which lead to hypertrophic cardiomyopathy, conduction abnormalities, heart failure, and early death. Cardiac transplantation can prolong life in many patients but is not curative and is associated with serious complications. In vitro evidence suggests that genetic correction of the LAMP2B (a specific pathogenic isoform of Danon disease) could restore cardiomyocyte function. This phase one study investigated RP-A501 gene therapy among seven male patients with Danon disease between ages 11 and 21. A single infusion of RP-A501 was administered alongside an immunomodulatory regimen. One patient with impaired baseline LVEF developed grade four thrombotic microangiopathy with thrombocytopenia and experienced Danon disease progression, subsequently undergoing heart transplantation. In the remaining patients with normal baseline LVEF, cardiac expression of LAMP2 along with clinical improvements were observed between 24 and 54 months. Despite its small size and subjective symptom assessment by aware investigators, these results suggested that RP-A501 was generally safe and associated with cardiac expression of LAMP2 and clinical improvements by 54 months in male patients with Danon disease.

Click here to read the study in the NEJM (New England Journal of Medicine)

In-Depth [randomized controlled trial]: This was an open-label, non-randomized study evaluating the safety and efficacy of RP-A501, a gene therapy consisting of AAV9.LAMP2B transgene, in male patients with Danon disease. Male patients aged 8 or older (or 15 years for earlier cohorts) who had a confirmed or likely pathogenic LAMP2 variant with cardiac involvement and heart failure symptoms. Seven patients received a single intravenous infusion of RP-A501 in three cohorts with varying dosages: cohort 1 (6.7E13 copies/kg) for adults and adolescents (≥15 years of age), cohort 2 (1.1E14 copies/kg) for adults and adolescents, and cohort 3 (6.7E13 copies/kg) for pediatric patients (8-14 years of age). The primary outcomes were safety, myocardial LAMP2 transduction and expression, and stabilization or improvement of heart failure symptoms and cardiac structure. One patient, who received the high-dose RP-A501, developed complement-mediated thrombotic microangiography with resultant thrombocytopenia and acute kidney injury. This patient had an impaired LVEF (32%) at baseline and experienced disease progression leading to heart failure. They underwent heart transplantation five months after the treatment and the explanted heart demonstrated evidence of disease progression without immunologic complications. Between 24 and 54 months, the remaining six patients were found to have cardiac LAMP2 expression and demonstrated a reduction from baseline in or stabilization of left ventricular mass index, LVEF preservation, and reduction in or stabilization of levels of cardiac troponin I and pro-B-type natriuretic peptide. The most common adverse events were vomiting, headache, myopathy, and elevated alanine aminotransferase levels. This study suggested that RP-A501 was generally safe and associated with cardiac expression of LAMP2 and clinical improvements in male patients with Danon disease, prompting further investigation into its use.

RELATED REPORTS

VS-041 reduced NT-proBNP after 28 days in a phase 1c HFpEF trial

Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: #cardiologyAAV9.LAMP2B gene therapychronic diseaseDanon diseasegene therapyheart failure
Previous Post

Male partner treatment lowers the risk of bacterial vaginosis reoccurrence

Next Post

Short sleep duration associated with increased risk of diabetes

RelatedReports

A heart on one side of a scale balances against a tablet on the other, suggesting evaluation of heart health and medication in cardiology.
2MM Trial Briefs

VS-041 reduced NT-proBNP after 28 days in a phase 1c HFpEF trial

November 13, 2026
A parent and child are depicted holding hands on a seesaw with a DNA helix above them, symbolizing genetic influences.
Chronic Disease

Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome

September 28, 2026
A man is sleeping on his side with a caution symbol and tape beside him, while lung images are in the background, suggesting a focus on sleep and respiratory health.
Cardiology

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

September 23, 2026
Heart failure collage: an engraved heart with teal ventricles above a folded patchwork quilt, a teacup and house slippers
Weekly Rewinds

2 Minute Medicine Rewind July 20, 2026

July 20, 2026
Next Post
Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens

Short sleep duration associated with increased risk of diabetes

Surgical outcomes collage: an operating lamp above a steel tray of scalpel, forceps and scissors beside a folded drape

Preweekend surgeries may have higher risks of complications and mortality

Brain health collage: an engraved brain in side view, a branching neuron, a plain brain-slice silhouette and a reflex hammer

2 Minute Medicine Rewind March 17, 2025

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind November 16, 2026
  • ERX1000 plus semaglutide increased weight loss and metabolic measures in diet-induced obese mice
  • Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.